-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Tarsus Pharmaceuticals, Inc. quarterly/annual Revenues history and growth rate from Q1 2020 to Q3 2024.
- Tarsus Pharmaceuticals, Inc. Revenues for the quarter ending September 30, 2024 was $48.1M, a 2472% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. Revenues for the twelve months ending September 30, 2024 was $130M, a 802% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. annual Revenues for 2023 was $17.4M, a 32.4% decline from 2022.
- Tarsus Pharmaceuticals, Inc. annual Revenues for 2022 was $25.8M, a 54.7% decline from 2021.
- Tarsus Pharmaceuticals, Inc. annual Revenues for 2021 was $57M.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)